BridgeBio Pharma Inc (NAS:BBIO)
$ 27.94 0.18 (0.65%) Market Cap: 5.23 Bil Enterprise Value: 6.44 Bil PE Ratio: 0 PB Ratio: 0 GF Score: 54/100

BridgeBio Pharma Inc at Morgan Stanley Global Healthcare Conference Transcript

Sep 12, 2023 / 02:50PM GMT
Release Date Price: $28.55 (+0.07%)
Unidentified Analyst

Good morning. I'm just going to mention the research disclosure for important disclosures, please see the Morgan Stanley research disclosure website at www.morganstanley.com/researchdisclosures. If you have any questions, please reach out to your Morgan Stanley sales representative.

Neil Kumar, very nice to see you and what a difference a year makes. My goodness, when we were sitting here last year, we were having very different discussions. Congratulations on your stunning clinical trial results, both in ATTR-CM and achondroplasia. You've got quite a portfolio, and I think there's going to be a lot to discuss today.

Neil Kumar
BridgeBio Pharma, Inc. - Co-Founder, President, CEO & Director

Thanks for having me, and I appreciate it, hosting in the downtimes and I'm so excited for the conversation.

Questions & Answers

Unidentified Analyst

Great. Well, let's start with acoramidis in terms of the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot